tirzepatide eli lily F.D.A. Approves New Obesity Drug That Will Compete With Wegovy Lilly, Novo Fight Weight Loss

Both face frequent drug shortages based on high demand and limited supply

Tirzepatide (Mounjaro, Zepbound) is an FDA-approved dual GIP/GLP-1 receptor agonist for type 2 diabetes and chronic weight management

Also, get evaluated if you see patchy baldness, sudden or extreme thinning in specific areas, scalp irritation, or systemic symptoms such as: Fatigue Weakness Sensitivity to cold or heat Those signs could indicate: Thyroid problems Iron deficiency anemia Other conditions that need targeted treatment Which Blood Tests and Checks Might Be Useful A clinician will often order tests to look for common contributors to shedding

The maintenance dose of Tirzepatide depends on individual response, but it typically ranges between 5 mg, 10 mg, or 15 mg once weekly

I often tell my patients that we cannot change our genetics, our family or personal medical history, but we can make lifestyle changes that can make a lasting difference in our babys health and ours